Tatva Chintan Stock Performance
as on March 13, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,138.00₹1,175.90
1.06%
Downside
2.23%
Upside

52 Week's Low
52 Week's High
₹621.00₹1,610.00
46.01%
Downside
39.98%
Upside

Tatva Chintan share price movements today
- Previous Close
- ₹1,158.60
- Open
- ₹1,164.80
- Volume
- 58.91K
- Upper Circuit
- ₹1,390.30
- Lower Circuit
- ₹926.90
- Day's Low - High
- ₹1,138.00 - ₹1,175.90
- 52 Week Low - High
- ₹621.00 - ₹1,610.00
Tatva Chintan Historical Returns
- 1 Month Return
- -2.91 %
- 3 Month Return
- -21.89 %
- 1 Year Return
- + 79.92 %
- 3 Year Return
- -36.18 %
- 5 Year Return
- -50.26 %
Tatva Chintan Fundamentals
as on March 13, 2026 at 4:01 pm IST
Market Cap
₹2,690.55 Cr
Return on Equity (ROE)
0.05
PE Ratio (TTM)
82.1
Return on capital employed (ROCE)
0.25
Industry PE ratio
44.94
Beta (LTM)
1.08
P/B Ratio
2.2
Dividend Yield
0.15
PEG Ratio
10.39
Quarterly Earnings Growth YOY
10735.71
EPS (TTM)
2.44
Sector
Chemicals
Book Value
315.84
Technical Analysis
Bearish
View Technical Analysis
Tatva Chintan Stock Valuation
as on March 13, 2026 at 4:01 pm IST
Tatva Chintan in the last 5 years
Lowest (44.37x)
October 20, 2021
Industry (44.94x)
March 13, 2026
Today (82.10x)
March 13, 2026
Highest (399.67x)
June 9, 2025
Today’s Price to Earnings Ratio: 82.10x
Tatva Chintan Pharma Chem Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Tatva Chintan with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 2,690.55 | -10.05% | 0.52 | 5 | 382 | |
| NA | 968.70 | 80.89% | 0.00 | NA | NA | |
| BUY | 6,542.09 | 10.3% | 0.75 | 60 | 3,345 | |
| NA | 3,399.38 | 245.45% | 0.00 | 88 | 556 | |
| NA | 83.11 | 16.91% | 0.65 | NA | 18 |
Market expectation of Tatva Chintan Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
25.00%
Buy
25.00%
Hold
50.00%
Sell
Tatva Chintan Stock’s Investor Sentiment and Interest
Search interest for Tatva Chintan Pharma Chem Ltd Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Tatva Chintan Pharma Chem Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Tatva Chintan Pharma Chem Ltd Annual Profit & Loss
Figures in Rupees Crores
Tatva Chintan Pharma Chem Ltd Cash Flow
Figures in Rupees Crores
Tatva Chintan Corporate Actions
View detailed summary of the earnings and dividend history of Tatva Chintan.
Tatva Chintan Pharma Chem Ltd Earnings Results
Tatva Chintan Pharma Chem Ltd’s net profit jumped 10735.71% since last year same period to ₹15.17Cr in the Q3 2025-2026. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 52.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsTatva Chintan Pharma Chem Ltd Dividends May,2025
In the quarter ending March 2025, Tatva Chintan Pharma Chem Ltd has declared dividend of ₹1.00 per share on 02 May 2025 - translating a dividend yield of 0.26%.
Read More about Dividends
Indices Featuring Tatva Chintan Stock
Check stock indices that include Tatva Chintan.
Insights on Tatva Chintan Pharma Chem Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 3.39% to 4.17% in Dec 2025 quarter
POSITIVE IMPACTBest in 1 Year

In the last 1 year, TATVA has outperformed top 5 stocks with highest market-cap in Specialty Chemicals
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 6 quarters, 83.87 Cr → 133.07 Cr (in ₹), with an average increase of 8.6% per quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 6 quarters, -0.66 Cr → 15.17 Cr (in ₹), with an average increase of 162.0% per quarter
POSITIVE IMPACTPrice Rise

In the last 1 year, TATVA stock has moved up by 79.9%
NO EFFECTAgainst Peers

In the last 3 years, Anupam Rasayan India Ltd has given 66.8% return, outperforming this stock by 103.0%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 72.02% of holdings in Dec 2025 quarter
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 20.73% to 20.48% in Dec 2025 quarter
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 3.82% to 3.26% in Dec 2025 quarter
About Tatva Chintan Pharma Chem Ltd
Revenue: ₹131.33Cr as on December 2025 (Q3 FY26)
Net Profit: ₹15.17Cr as on December 2025 (Q3 FY26)
Listing date: 29 Jul, 2021
Chairperson Name: Chintan Nitinkumar Shah
| Organisation | Tatva Chintan Pharma Chem Ltd |
| Headquarters | Vadodara |
| Industry | Chemicals |
| CEO | Chintan Nitinkumar Shah |
| E-voting on shares | Click here to vote |
FAQs
What is Tatva Chintan share price today?
Tatva Chintan share price today stands at ₹1150.2 as on at the close of the market. Tatva Chintan share today touched a day high of ₹1175.9 and a low of ₹1138.
What is the 52 week high and 52 week low range for Tatva Chintan share?
Tatva Chintan touched a 52 week high of ₹1610 and a 52 week low of ₹621. Tatva Chintan share price today i.e. is closed at ₹1150.2, which is -28.56% down from its 52 week high and 85.22% up from its 52 week low.
What is Tatva Chintan's market capitalisation today?
Tatva Chintan market capitalisation is ₹2,690.55 Cr as on .
How to buy Tatva Chintan shares?
To buy Tatva Chintan shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for TATVA or Tatva Chintan Pharma Chem Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Tatva Chintan shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Tatva Chintan trading volume today?
Tatva Chintan trading volume is 58.91K as on . This means that 58.91K shares of Tatva Chintan were bought and sold on the stock market during today's trading session.